moxifloxacin hydrochloride
moxifloxacin hydrochloride is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including MOXIFLOXACIN HYDROCHLORIDE, VIGAMOX, Moxifloxacin Ophthalmic Solution. Available dosage forms: tablet, film coated, solution/ drops, powder.
Drug Details
- Generic Name
- moxifloxacin hydrochloride
- Brand Names
- MOXIFLOXACIN HYDROCHLORIDE, VIGAMOX, Moxifloxacin Ophthalmic Solution, Moxifloxacin
- Application Number
- ANDA202632
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, SOLUTION/ DROPS, POWDER
- Routes
- ORAL, OPHTHALMIC
- Active Ingredients
- MOXIFLOXACIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* , Micrococcus luteus*, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri*, Streptococcus pneumoniae, Streptococcus viridans group , Acinetobacter lwoffii*, Haemophilus influenzae, Haemophilus parainfluenzae*, Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. ( 1 )